share_log

Jefferies Initiates Coverage On BioLife Solns With Buy Rating, Announces Price Target of $22

Jefferies Initiates Coverage On BioLife Solns With Buy Rating, Announces Price Target of $22

傑富瑞以買入評級開始對BioLife Solns進行報道,宣佈目標股價爲22美元
Moomoo 24/7 ·  04/04 07:18

Jefferies analyst Matthew Stanton initiates coverage on BioLife Solns (NASDAQ:BLFS) with a Buy rating and announces Price Target of $22.

傑富瑞分析師馬修·斯坦頓開始對BioLife Solns(納斯達克股票代碼:BLFS)進行報道,評級爲買入,並宣佈目標股價爲22美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論